Ultragenyx Pharmaceutical (RARE) Net Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,218.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 2,713.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,713.00 |
| Dec 31, 2025 | 8,648.00 |
| Sep 30, 2025 | 15,742.00 |
| Jun 30, 2025 | 10,799.00 |
| Mar 31, 2025 | 8,192.00 |
| Dec 31, 2024 | 41,008.00 |
| Sep 30, 2024 | -631.00 |
| Jun 30, 2024 | 5,126.00 |
| Mar 31, 2024 | -1,986.00 |
| Dec 31, 2023 | -7,095.00 |
| Sep 30, 2023 | -7,832.00 |
| Jun 30, 2023 | -18,859.00 |
| Mar 31, 2023 | 16,465.00 |
| Dec 31, 2022 | 11,505.00 |
| Sep 30, 2022 | 16,773.00 |
| Jun 30, 2022 | 23,364.00 |
| Mar 31, 2022 | 34,189.00 |
| Dec 31, 2021 | 39,045.00 |
| Sep 30, 2021 | 65,284.00 |
| Jun 30, 2021 | 27,137.00 |
| Mar 31, 2021 | -42,032.00 |
| Dec 31, 2020 | 463,934.00 |
| Sep 30, 2020 | 3.99 Mn |
| Dec 31, 2019 | 142.48 Mn |
| Sep 30, 2019 | 5.80 Mn |
| Jun 30, 2019 | 33.44 Mn |